TY - JOUR
T1 - Suppression of p53-activated gene, PAG608, attenuates methamphetamine-induced neurotoxicity
AU - Asanuma, Masato
AU - Miyazaki, Ikuko
AU - Higashi, Youichirou
AU - Diaz-Corrales, Francisco J.
AU - Shimizu, Masako
AU - Miyoshi, Ko
AU - Ogawa, Norio
N1 - Funding Information:
This work was supported in part by Health and Labour Sciences Research Grants for Specific Research, for Research on Measures for Intractable Diseases, for Research on Pharmaceutical and Medical Safety, for Research on Psychiatric and Neurological Diseases and Mental Health, and for Comprehensive Research on Aging and Health from the Japanese Ministry of Health, Labour and Welfare, by Grants-in-Aid for Scientific Research (C) and for Young Scientists (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and by Grants for Scientific Research from The Foundation of Sanyo Broadcasting.
PY - 2007/3/13
Y1 - 2007/3/13
N2 - The p53-activated gene 608 (PAG608) is a proapoptotic gene activated and regulated by p53 expression in oxidative stress-induced apoptosis of neuronal cells. In this study, we determined the role of PAG608 in methamphetamine-induced neurotoxicity. Treatment of mouse dopaminergic CATH.a cells with 2 mM methamphetamine increased PAG608 expression at 3 h followed by increase in phosphorylated p53 expression. Transient transfection of PAG608 antisense cDNA or RNA interference using PAG608 small interfering RNA significantly attenuated the dose-dependent decrease in cell viability of CATH.a cells by methamphetamine (1-4 mM) exposure. In monoaminergic neuronal B65 cells, which contain serotonin rather than dopamine, methamphetamine-induced cell death was also significantly but partially protected by transient transfection of PAG608 antisense cDNA. Furthermore, cell death of PC12 cells produced by methamphetamine (1-5 mM) was almost completely prevented by stable expression of PAG608 antisense cDNA, compared with significant reduction of cell viability in control PC12 cells. Our results showed that suppression of PAG608 using transient and stable transfection with PAG608 antisense cDNA or small interfering RNA attenuates methamphetamine-induced death of various monoaminergic neuronal cells, suggesting that methamphetamine neurotoxicity in monoaminergic cells is related, at least in part, to induction of PAG608 expression.
AB - The p53-activated gene 608 (PAG608) is a proapoptotic gene activated and regulated by p53 expression in oxidative stress-induced apoptosis of neuronal cells. In this study, we determined the role of PAG608 in methamphetamine-induced neurotoxicity. Treatment of mouse dopaminergic CATH.a cells with 2 mM methamphetamine increased PAG608 expression at 3 h followed by increase in phosphorylated p53 expression. Transient transfection of PAG608 antisense cDNA or RNA interference using PAG608 small interfering RNA significantly attenuated the dose-dependent decrease in cell viability of CATH.a cells by methamphetamine (1-4 mM) exposure. In monoaminergic neuronal B65 cells, which contain serotonin rather than dopamine, methamphetamine-induced cell death was also significantly but partially protected by transient transfection of PAG608 antisense cDNA. Furthermore, cell death of PC12 cells produced by methamphetamine (1-5 mM) was almost completely prevented by stable expression of PAG608 antisense cDNA, compared with significant reduction of cell viability in control PC12 cells. Our results showed that suppression of PAG608 using transient and stable transfection with PAG608 antisense cDNA or small interfering RNA attenuates methamphetamine-induced death of various monoaminergic neuronal cells, suggesting that methamphetamine neurotoxicity in monoaminergic cells is related, at least in part, to induction of PAG608 expression.
KW - Dopamine
KW - Methamphetamine
KW - Monoamine
KW - Neurotoxicity
KW - PAG608
KW - p53
UR - http://www.scopus.com/inward/record.url?scp=33847239085&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847239085&partnerID=8YFLogxK
U2 - 10.1016/j.neulet.2006.12.036
DO - 10.1016/j.neulet.2006.12.036
M3 - Article
C2 - 17234339
AN - SCOPUS:33847239085
SN - 0304-3940
VL - 414
SP - 263
EP - 267
JO - Neuroscience Letters
JF - Neuroscience Letters
IS - 3
ER -